112 related articles for article (PubMed ID: 23345506)
1. Getting rid of MPO-ANCA: a matter of disease subtype.
Bremer JP; Csernok E; Holle J; Gross WL; Moosig F
Rheumatology (Oxford); 2013 Apr; 52(4):752-4. PubMed ID: 23345506
[No Abstract] [Full Text] [Related]
2. [Anti-neutrophil cytoplasmic antibody(ANCA), MPO-ANCA, PR3-ANCA].
Takizawa H
Nihon Rinsho; 2010 Jun; 68 Suppl 6():694-6. PubMed ID: 20942166
[No Abstract] [Full Text] [Related]
3. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
Nakano H; Ozaki S
Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
[TBL] [Abstract][Full Text] [Related]
4. [Immunological tests: Anti-neutrophil cytoplasmic antibody].
Takizawa H
Nihon Rinsho; 2005 Jul; 63 Suppl 7():624-6. PubMed ID: 16111351
[No Abstract] [Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibodies and clinical phenotype in patients with Churg-Strauss syndrome.
Sinico RA; Bottero P; Guillevin L
J Allergy Clin Immunol; 2012 Dec; 130(6):1440; author reply 1440-1. PubMed ID: 23098809
[No Abstract] [Full Text] [Related]
6. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
7. [A case of Churg-Strauss syndrome in which positive rheumatoid factor and MPO-ANCA preceded the development of clinical symptoms of vasculitis].
Furuiye M; Konno K; Sumi Y; Ohtani Y; Sawada M; Umino T; Inase N; Miyake S; Yoshizawa Y
Nihon Kokyuki Gakkai Zasshi; 2001 Jun; 39(6):410-4. PubMed ID: 11530389
[TBL] [Abstract][Full Text] [Related]
8. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
9. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
10. Testing for antineutrophil cytoplasmic antibodies.
Zauli D; Grassi A; Ballardini G; Bianchi FB
Am J Clin Pathol; 2000 Mar; 113(3):455-6. PubMed ID: 10705826
[No Abstract] [Full Text] [Related]
11. Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis.
Xu PC; Chen M; Cui Z; Zhao MH
Rheumatology (Oxford); 2010 Nov; 49(11):2068-75. PubMed ID: 20675709
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
[TBL] [Abstract][Full Text] [Related]
13. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
14. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
[TBL] [Abstract][Full Text] [Related]
16. L29. Relevance of anti-LAMP-2 in vasculitis: why the controversy.
Kain R
Presse Med; 2013 Apr; 42(4 Pt 2):584-8. PubMed ID: 23453500
[No Abstract] [Full Text] [Related]
17. [A case of Churg-Strauss syndrome in which MPO-ANCA (antibodies to myeloperoxidase) appeared to reflect the disease activity].
Nakagawa A; Yamaguchi T; Amano H; Takao T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):543-7. PubMed ID: 7609341
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
Pollock W; Jovanovich S; Savige J
J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
[TBL] [Abstract][Full Text] [Related]
19. [General characteristics of 29 patients with small vessel vasculitis].
Di Benedetto N; López Mujica MX; Fernández ME; Tourón M; Muñoz SA; Allievi A
Medicina (B Aires); 2010; 70(2):127-32. PubMed ID: 20447894
[TBL] [Abstract][Full Text] [Related]
20. Biotinylation of ANCA target antigen improves assay performance for PR3-ELISA but not MPO-ELISA.
Hayman MW; Slade CA; Spellerberg MB; O'Donnell JL
Pathology; 2013 Aug; 45(5):525-7. PubMed ID: 23842044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
